Diabetes

Pharmac needs to “try a hell of a lot harder” to engage with stakeholders, especially patients, on how it operates, John Baker says 

A study showing disparities in metformin prescribing is an important step in unpicking a complex situation, says Royal New Zealand College of General Practitioners clinical director and Porirua GP Bryan Betty

Māori patients receive fewer prescriptions for the common diabetes medication Metformin than non-Māori despite suffering from the disease at twice the rate, according to a new study by the University of Waikato

Pharmacist and reclassification expert Natalie Gauld gives a first-hand account of how the relentless monitoring of type 1 diabetes can lead to burnout, and how health professionals can support their patients 

A longitudinal study of the treatment offered to 45,000 south Auckland diabetes patients is well-intentioned while fundamentally flawed, says Pacific health researcher

A 24-year longitudinal study of 45,000 south Auckland patients estimates there are almost 19,000 extra deaths annually among Māori with type 2 diabetes

All seven Auckland PHOs and Diabetes Foundation Aotearoa have attacked Pharmac’s drug funding proposal for new diabetes drugs, claiming restrictions will hurt Māori and Pasifika

Pharmac is depriving a group of patients access to the benefit of insulin pumps, a child health academic and paediatrician says

New research suggests the ability to speak te reo Māori may be a protective factor for developing type 2 diabetes 

Taupo could be a type II diabetes, medication free ‘island’ if a GP and his colleagues have their way